Full Length Research Paper
References
|
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P (2005). The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129(1): 113-121. Crossref |
||||
|
Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G (2001). Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33(6):1358-64. Crossref |
||||
|
Angulo P (2002). Nonalcoholic fatty liver disease. N. Engl. J. Med. 346(16):1221-31. Crossref |
||||
|
Bravo AA, Sheth SG, Chopra S (2001). Liver biopsy. N. Engl. J Med. 344(7):495-500. Crossref |
||||
|
Brook G, Soriano V, Bergin C (2010).European guideline for the management of hepatitis B and C virus infections. Int. J. STD AIDS 21(10):669-78. Crossref |
||||
|
Charatcharoenwitthaya P, Lindor KD (2007). Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin. Liver Dis. 11(1):37-54, viii. Crossref |
||||
|
Cho, CS, Curran S, Schwartz LH, Kooby DA, Klimstra DS, Shia J, Munoz A, Fong Y, Jarnagin WR, DeMatteo RP, Blumgart LH, D'Angelica MI (2008). Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J. Am. Coll. Surg. 206(3): 480-8. Crossref |
||||
|
Cobbold J, Lim A, Wylezinska M, Cunningham C, Crossey M, Thomas H, Patel N, Cox J, Taylor-Robinson S (2006). Magnetic resonance and ultrasound techniques for the evaluation of hepatic fibrosis. Hepatology 43(6):1401-1402. Crossref |
||||
|
Cunningham, CH, Vigneron DB, Marjanska M, Chen AP, Xu D, Hurd RE, Kurhanewicz J, Garwood M, Pauly JM (2005). Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn. Reson. Med. 53(5):1033-9. Crossref |
||||
|
Farrell GC, Larter CZ (2006). Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43(2 Suppl 1):S99-S112. Crossref |
||||
|
Fischbach F, Bruhn H (2008). Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int. 28(3):297-307. Crossref |
||||
|
Hamer, OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB (2006). Fatty liver: imaging patterns and pitfalls. Radiographics 26(6):1637-53. Crossref |
||||
|
Hom, JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll PR, Kurhanewicz J (2006). Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. Radiology 238(1):192-9. Crossref |
||||
|
Hoofnagle JH (2002). Course and outcome of hepatitis C. Hepatology 36(5 Suppl 1):S21-9. Crossref |
||||
|
Ishak, K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al. (1995). Histological grading and staging of chronic hepatitis. J. Hepatol. 22(6):696-9. Crossref |
||||
|
Joseph AE, Saverymuttu SH (1991). Ultrasound in the assessment of diffuse parenchymal liver disease. Clin. Radiol. 44(4):219-21. Crossref |
||||
|
Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J, and Cirrhosis Asian Lamivudine Multicentre Study Group (2004). Lamivudine for patients with chronic hepatitis B and advanced liver disease. N. Engl. J. Med. 351(15):1521-31. Crossref |
||||
|
Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, Croce LS, Grigolato P, Paoletti S, de Bernard B, et al. (1995). Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J. Magn. Reson. Imaging 5(3):281-5. Crossref |
||||
|
Mehta SR, Thomas EL, Bell JD, Johnston DG, and Taylor-Robinson SD (2008). Non-invasive means of measuring hepatic fat content. World J. Gastroenterol. 14(22):3476-83. Crossref |
||||
|
Michaelis, T, Merboldt KD, Bruhn H, Hanicke W, Frahm J (1993). Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187(1): 219-27. Crossref |
||||
|
Opstad, KS, Bell BA, Griffiths JR, Howe FA (2008). An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed. 21(7): p. 677-85. Crossref |
||||
|
Pearlman BL (2012). Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care. Lancet Infect. Dis. 12(9):717-728. Crossref |
||||
|
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T (2005). Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128(7):1898-906. Crossref |
||||
|
Rector RS, Thyfault JP, Wei Y, Ibdah JA (2008). Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 14(2):185-192. Crossref |
||||
|
Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER (2002). Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 97(10):2614-2618. Crossref |
||||
|
Ross B, Bluml S (2001). Magnetic resonance spectroscopy of the human brain. Anat. Rec. 265(2):54-84. Crossref |
||||
|
Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, Carlotto A, Bozzola L, Smedile A, Negro F (2004). Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 53(3): 406-12. Crossref |
||||
|
Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ (2002). The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123(3): 745-50. Crossref |
||||
| Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT (1999). Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am. J. Physiol. 276(5 Pt 1):E977-89. | ||||
|
Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL (2005). Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288(2):E462-8. Crossref |
||||
|
Thomas EL, Hamilton G, Patel N, O'Dwyer R, Dore CJ, Goldin RD, Bell JD, Taylor-Robinson SD (2005). Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54(1):122-127. Crossref |
||||
|
Williams R (2006). Global challenges in liver disease. Hepatology 44(3): 521-526. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
